Expression of STAT family and its potency to prognosis in uterine corpus endometrial carcinoma

Author:

Li Luyi1,Li Sihui2,Zhou Hongdi1

Affiliation:

1. Tongji University School of Medicine

2. Women's Hospital, Zhejiang University

Abstract

Abstract Purpose Signal Transducer and Activators of Transcription (STAT) family is a full set of transcription factors, acting a pivotal role in normal physiological and pathological process. Evidence manifests these transcription factors are involved in tumorigenesis of various cancers including uterine corpus endometrial carcinoma (UCEC). Whereas, the differential expression pattern and prognostic value of individual STAT remain to be elucidated in UCEC. Methods and results In this study, the data of expression (HTSeq-FPKM) and data of clinical pathology of UCEC patients and normal samples of endometrium were downloaded via the data portal of TCGA.Based on TCGA database, STAT1 was increased, conversely STAT3/5A/5B/6 were decreased in UCEC patients. Furthermore, expressions of STAT1 and STAT6 were markedly associated with TNM stage and tumor grade. Multivariate analysis adjusted for histological type, patient age, tumor grade and TMN stage revealed that STAT4 and STAT6 were independent prognostic factors for overall survival (OS). Additionally, gene set enrichment analysis (GSEA) revealed that pathways of endometrial cancer, JAK-STAT, WNT, mTOR and p53 were differentially enriched in STAT1 high expression phenotype. And STAT1 was co-expressed with pik3ca, β-catenin(CTNNB1), wnt3a, wnt7a genes, as well, could co-mutated with pik3ca,TP53, APC, which were all key factors in PI3K-AKT-mTOR and WNT signaling pathway. Conclusion Thus, results supported that STAT1 might be used as a potential therapeutic target meanwhile STAT4 and STAT6 might act as prognostic molecular markers of improved survival for UCEC.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3